An underground economy for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.
Experimental Treatment Gaining Traction Via Social Media
The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are encouraged to message these profiles privately for source information, while also obtaining discount codes.
Active Trade on Messaging Platforms
Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Professionals Voice Worries
However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to individuals injecting products of uncertain source.
Some experts said the demand for retatrutide could be connected to the increasing price of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for personal consumption under the British medical regulations.
Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, advertising, and consumer regulations, risking fines, legal action or prison.
Platform Reaction and Content Removal
Based on TikTok, the platform has taken down violative content and banned associated keywords and search suggestions. The company said it was dedicated to maintaining the platform safe and allocating resources in enhancing compliance measures.
Digital Marketplace Activities
Investigations also found groups with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly displays groups with thousands of members, filled with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at home.
After moments of entering one community, a vendor shared WhatsApp details, where the majority of purchases take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.
Product Details and Costs
Within these groups, posts display black plastic parcels with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at residence with purified liquid, or pre-filled pens usually sold at £160 for 20mg. When asked how much time a pen should last, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Measures
A representative for the messaging service stated it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they cannot confirm. Although the research behind this drug is valid, these digital products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.
Her team has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to potentially significant medical dangers”.
